Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #51,501 to #51,550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neonatal respiratory distress syndrome physical examination (3 revisions)
  2. Neonatal respiratory distress syndrome primary prevention (3 revisions)
  3. Neoplasia (3 revisions)
  4. Neosporin (3 revisions)
  5. Nephrocalcinosis causes (3 revisions)
  6. Nephrogenic diabetes insipidus causes (3 revisions)
  7. Nephrogenic diabetes insipidus overview (3 revisions)
  8. Nephrogenic diabetes insipidus tertiary prevention (3 revisions)
  9. Nephrogenic fibrosing dermopathy overview (3 revisions)
  10. Nephronectin (3 revisions)
  11. Nephronophthisis (3 revisions)
  12. Nephropathy (3 revisions)
  13. Nephroptosis x ray (3 revisions)
  14. Nephrotic syndrome secondary prevention (3 revisions)
  15. Nesidioblastosis (3 revisions)
  16. Nested case-control study (3 revisions)
  17. Nestin (protein) (3 revisions)
  18. Neural tube defects (3 revisions)
  19. Neuralgia natural history, complications and prognosis (3 revisions)
  20. Neuralgia risk factors (3 revisions)
  21. Neuralgia surgery (3 revisions)
  22. Neuraminidase (3 revisions)
  23. Neuregulin 4 (3 revisions)
  24. Neurexin (3 revisions)
  25. NeuroElectric Therapy (3 revisions)
  26. Neuroblastoma RAS viral oncogene homolog (3 revisions)
  27. Neuroblastoma case study one (3 revisions)
  28. Neurocardiogenic syncope medical treatment (3 revisions)
  29. Neurocognitive disorder due to another medical condition (3 revisions)
  30. Neuroendocrine tumors case study one (3 revisions)
  31. Neuroepithelial cell (3 revisions)
  32. Neurofibroma cost-effectiveness of therapy (3 revisions)
  33. Neurofibroma diagnostic criteria (3 revisions)
  34. Neurofibromatosis type 1 CT scan (3 revisions)
  35. Neurofibromatosis type 1 classification (3 revisions)
  36. Neurofibromatosis type 1 history and symptoms (3 revisions)
  37. Neurofibromatosis type 1 secondary prevention (3 revisions)
  38. Neurofibromatosis type II (3 revisions)
  39. Neurofilament (3 revisions)
  40. Neurogenic bladder (patient information) (3 revisions)
  41. Neurogenic inflammation (3 revisions)
  42. Neurogenins (3 revisions)
  43. Neuroglobin (3 revisions)
  44. Neurokinin A (3 revisions)
  45. Neuroligin (3 revisions)
  46. Neuromedin U receptor 1 (3 revisions)
  47. Neuromedin U receptor 2 (3 revisions)
  48. Neuromuscular junction disease (3 revisions)
  49. Neuron-Specific Enolase (NSE) (3 revisions)
  50. Neuropeptide B/W receptor (3 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)